Bruce L. A. Carter, Director at Mirati Therapeutics, Inc. (MRTX), sold 4,000 shares at $106.86 ($427K) on 2020-05-18, disclosed to the SEC on 2020-05-20.
Open-market sale of $427k MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRTX | SELL | 2021-04-06 | $746K | — | Filing → |
| MRTX | SELL | 2021-02-03 | $430K | — | Filing → |
| MRTX | SELL | 2020-12-16 | $1.1M | — | Filing → |